Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone

Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone

Junfeng Ban, Yan Zhang, Xin Huang, Guanghan Deng, Dongzhi Hou, Yanzhong Chen, Zhufen Lu Guangdong Provincial Key Laboratory of Advanced Drug Delivery Systems, Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China Abstract: Drug delivery carriers can maintain effectiv...

Full description

Bibliographic Details
Main Authors:	Ban J, Zhang Y, Huang X, Deng GH, Hou DZ, Chen YZ, Lu ZF
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-02-01
Series:	International Journal of Nanomedicine
Subjects:	ocular drug delivery system local bioavailability dexamethasone eye drop administration
Online Access:	https://www.dovepress.com/corneal-permeation-properties-of-a-charged-lipid-nanoparticle-carrier--peer-reviewed-article-IJN

Similar Items

Biopharmaceutical Assessment of Dexamethasone Acetate-Based Hydrogels Combining Hydroxypropyl Cyclodextrins and Polysaccharides for Ocular Delivery
by: Roseline Mazet, et al.
Published: (2020-07-01)

Preparation and Evaluation of Topically Applied Azithromycin Based on Sodium Hyaluronate in Treatment of Conjunctivitis
by: Qian Chen, et al.
Published: (2019-04-01)

Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease
by: Sangeeta Kumari, et al.
Published: (2021-06-01)

Investigation of Combined Cyclodextrin and Hydrogel Formulation for Ocular Delivery of Dexamethasone Acetate by Means of Experimental Designs
by: Roseline Mazet, et al.
Published: (2018-12-01)

Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the Hospital Pharmacy Departments
by: Anxo Fernández-Ferreiro, et al.
Published: (2016-12-01)

The effect of loteprednol suspension eye drops after corneal transplantation
by: Yingxin Chen, et al.
Published: (2021-05-01)

Metabolomics analysis revealed acupuncture treatment target the upstream for dry eye disease
by: Jun Rao, et al.
Published: (2021-03-01)

Dexamethasone distribution characteristic following controllable continuous sub-tenon drug delivery in rabbit
by: Xuetao Huang, et al.
Published: (2017-01-01)

Pharmacodynamic and Pharmacokinetic Studies of β-Cyclodextrin:Dexamethasone Acetate Complexes in Mice
by: Patrik Oening Rodrigues, et al.
Published: (2014-12-01)

Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient
by: Rathini Lilian David, et al.
Published: (2020-01-01)

Pullulan Based Bioconjugates for Ocular Dexamethasone Delivery
by: Eva Kicková, et al.
Published: (2021-05-01)

Local use of dexamethasone in the treatment of ocular myasthenia gravis
by: Minghua Shi, et al.
Published: (2020-10-01)

Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy
by: Brooks CC, et al.
Published: (2020-01-01)

Retinal injury following intravitreal injection of a dexamethasone implant in a non-vitrectimised eye
by: M Arvind Jain, et al.
Published: (2020-01-01)

Analysis of ocular toxicity of fluconazole and voriconazole eyedrops using HET-CAM
by: A. Fernández-Ferreiro, et al.
Published: (2014-07-01)

Effect of intravitreal dexamethasone implant on the contralateral eye in recalcitrant radiation maculopathy
by: Srishti Kamalmani Gulati, et al.
Published: (2019-01-01)

The Case of Сushing Syndrome in a Child of 15 Years after Prolonged Endonasal Use of Dexamethasone
by: S. S. Postnikov, et al.
Published: (2018-12-01)

The short-term effects of intravitreal aflibercept injections and dexamethasone implant on ocular hemodynamics in retinal vein occlusions
by: Ciloglu E, et al.
Published: (2019-07-01)

Clinical Application and Efficacy of Silver Drug in Ophthalmology: A Literature Review and New Formulation of EYE Drops with Drug Silver (I) Complex of Metronidazole with Improved Dosage Form
by: Arleta Waszczykowska, et al.
Published: (2021-02-01)

Comparison of the effects of intravitreal bevacizumab and dexamethasone in experimental posterior penetrating eye injury
by: Ayse Oner, et al.
Published: (2018-04-01)

Trends in Topical Prescriptional Therapy for Old Patients With Dry Eye Disease in Six Major Areas of China: 2013–2019
by: Zhenwei Yu, et al.
Published: (2021-08-01)

Topical Use of Angiopoietin-like Protein 2 RNAi-loaded Lipid Nanoparticles Suppresses Corneal Neovascularization
by: Yukako Taketani, et al.
Published: (2016-01-01)

Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone
by: Mitra Alami-milani, et al.
Published: (2018-02-01)

Evaluating the Efficacy of Topical and Subconjunctival Diclofenac in the Improvement of Corneal Alkali Burn in Rabbits
by: Noushin Esmaeeli, et al.
Published: (2016-12-01)

Development and Evaluation of a Novel Microemulsion of Dexamethasone and Tobramycin for Topical Ocular Administration
by: Bachu, Rinda Devi
Published: (2017)

Synthesis and Ex Vivo Trans-Corneal Permeation of Penetratin Analogues as Ophthalmic Carriers: Preliminary Results
by: Silvia Pescina, et al.
Published: (2020-08-01)

Effect of Different Treatment Regimen with Dexamethasone and Acetylcysteine on Corneal Wound Healing in Rabbits
by: Ali Asghar Sarchahi, et al.
Published: (2011-09-01)

The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer
by: Wannamaker KW, et al.
Published: (2019-06-01)

The Effect of 0.01% Atropine Eye Drops on the Ocular Surface in Children for the Control of Myopia—The Primary Results from a Six-Month Prospective Study
by: Cheng J, et al.
Published: (2020-08-01)

Difficulties with self instillation of eye drops and its impact on intraocular pressure in glaucoma patients
by: Shalini Virani, et al.
Published: (2015-01-01)

Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
by: Eliana B. Souto, et al.
Published: (2019-09-01)

Polysaccharides in Ocular Drug Delivery
by: Natallia Dubashynskaya, et al.
Published: (2019-12-01)

THE EFFECT OF DEXAMETHASONE ON POST TONSILLECTOMY MORBIDITIES IN CHILDREN
by: Raid Yaqoub Yousef, et al.
Published: (2011-12-01)

Synthesis of Tilmicosin Nanostructured Lipid Carriers for Improved Oral Delivery in Broilers: Physiochemical Characterization and Cellular Permeation
by: Benazir Sahito, et al.
Published: (2020-01-01)

IV Dexamethasone for Acute Migraine
by: J Gordon Millichap
Published: (2007-12-01)

Effect of Eye Rubbing on Corneal Biomechanical Properties and Intraocular Pressure
by: Refik Oltulu, et al.
Published: (2014-08-01)

Effect of Curcumin on Lipid Profile, Oxidative Stress and Blood Glucose in Experimental Dexamethasone-Induced Diabetes in Rats
by: Azizollah Pourmahmoudi, et al.
Published: (2021-01-01)

Protective effect of Dexamethasone combined with hypertonic solution on corneal endothelium in rabbit eyes
by: Biao Li, et al.
Published: (2020-09-01)

Rehabilitation of ocular defect: A modified technique to produce corneal prominence
by: Sumit Kumar Misra, et al.
Published: (2018-01-01)

A Randomized Fellow-Eye Clinical Trial to Evaluate Patient Preference for Dexamethasone Intracanalicular Insert or Topical Prednisolone Acetate for Control of Postoperative Symptoms Following Bilateral Femtosecond Laser in Site Keratomileusis (LASIK)
by: Greenwood MD, et al.
Published: (2020-08-01)